Founded by Carlos Monteiro, Biojam stands out in the Iberian Peninsula in the field of paediatric oncology. Innovation is in the pharmaceutical company's DNA, as its CEO points out: "We work every day to develop new products or innovative administration solutions, as in the paradigmatic case of the new form of therapeutic administration for Acute Lymphoblastic Leukaemia."
Source: Expresso
